Pfizer acquisition of cancer drug company could advance oncology research

Published Online: Aug 23,2016 Laurie Toich, Assistant Editor Pfizer recently announced its plans to acquire Medivation, a biopharmaceutical company that develops molecules for oncology. Recent health insurer mergers could have deterred the $14 billion deal, but Pfizer and Medivation’s boards of directors approved the merger, and expect that shares will increase immediately, according to a press release from Pfizer. “The proposed …

Sparking innovation with suppliers

WHITEPAPER by: Giles Breault, Principal and co-founder of The Beyond Group. Sammy Rashed, Principal and co-founder of The Beyond Group.  For some time now we have been delving into the question of what procurement teams imagine themselves becoming. The question may seem sophomoric on the surface but there are plenty of indicators that the same old results will no longer earn you a seat …

Ajay Gautam of AstraZeneca spoke at BioPharma Mexico 2014

AstraZeneca’s Ajay Gautam on innovation in emerging markets

Last year’s BioPharma Mexico was a huge success, and we were excited to have Ajay Gautam, Executive Director and Head of Emerging Markets for AstraZeneca, as one of our speakers. Ajay has a broad experience in Big Pharma, start-ups, private equity, and venture capital with the last 7 years spent in the Emerging Markets of Latin America, Middle East, and Northern Africa. In …

“Beyond the pill: partnerships in health for customer innovations and improved health outcomes”

At last year’s 2014 Pharma Engagement Live event, Christian Isler, Formerly Global Head of Solution and Product Development, Pfizer Integrated Health, gave the presentation “Beyond the pill: partnerships in health for customer innovations and improved health outcomes.” Download and learn: The current model is broken Behaviour is the biggest driver of premmature death Modifiable health behaviours Common response to these problems …

Innovative partnerships to bring health apps into mainstream healthcare and support

Dee O’Sullvan, Director, My health maps and Patient View, investigates in her presentation given at last year’s Pharma Engagement Live event, why health apps are important to patients, healthcare and pharma. Download and learn: The unavoidable logic of health apps How are pharma and HCP’s to respond? Important developments in the health app market Patients want to use apps with …

disruptive, innovation, clinical trials, clinical, clinical innovation congress

2014 Report: Game changing innovation in clinical trials

At last year’s Disruptive Innovation in Clinical Trials event, International Innovation attended and subsequently wrote a piece on the relevance of disruption in this industry and the importance of a gathering of professionals to discuss the matter in greater depth. Download the report to learn: What is disruptive innovation? The patient centric revolution What lessons can be learned How study …

infographic, clinical, clinical trials, innovation, disruptive innovation, clinical innovation, clinical innovation congress

Ebook: Clinical Innovation – The story so far… in pictures

  We’ve recently introduced new formats and new innovative ways to demonstrate the content given at our conferences. One of the latest introductions is the use of graphic reporting. What’s a graphic reporter? A graphic reporter is someone who creates infographics concurrently with a presenter at the event – kind of like an interpreter, but with pictures. This has livened up our …

Jae Chung, Oliver Timmis, infographics, clinical innovation, patient led clinical trials

Infographic: Innovative disruption in clinical trials

We’ve recently introduced new formats and new innovative ways to demonstrate the content given at our conferences. One of the latest introductions is the use of graphic reporting at our conferences.  What’s a graphic reporter? A graphic reporter is someone who creates infographics concurrently with a presenter at the event – kind of like an interpreter, but with pictures. This …

Filling the Innovation Gap with Big Data

Data and information form the cornerstone of innovation, and it will take a change in mindset for the pharmaceutical industry to fill the innovation gap and change the way drug research is conducted. Drug approval has been flat for the last two decades, while the cost of drug development is constantly rising. Solid real world evidence of the drug performance …

Top 5 Trends in Clinical Partnering and Outsourcing

  Clinical Outsourcing and Partnering is entering a new age of popularity and it looks set to prosper. A report by Transparency Market Research indicates that the outsourced research market is expected to be worth $65.03 billion by 2018. Since the 1980s, more and more pharma, biopharma and biotechs have turned to clinical outsourcing and partnering. As the agenda for …